P

Inventor

MCBRIDE WILLIAM J

US84 patents
⚠️ This page may combine multiple inventors who share the name “MCBRIDE WILLIAM J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

IMMUNOMEDICS INC

25 patents
US6962702B2Nov 8, 2005

Production and use of novel peptide-based agents for use with bi-specific antibodies

IMMUNOMEDICS INC126 citations99
US7597876B2Oct 6, 2009

Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules

IMMUNOMEDICS INC55 citations98
US7563433B2Jul 21, 2009

Methods and compositions for F-18 labeling of proteins, peptides and other molecules

IMMUNOMEDICS INC64 citations98
US7138103B2Nov 21, 2006

Use of bi-specific antibodies for pre-targeting diagnosis and therapy

IMMUNOMEDICS INC65 citations98
US7074405B1Jul 11, 2006

Use of bi-specific antibodies for pre-targeting diagnosis and therapy

IMMUNOMEDICS INC61 citations96
US7011816B2Mar 14, 2006

Labeling targeting agents with gallium-68 and gallium-67

IMMUNOMEDICS INC52 citations96
US6126916AOct 3, 2000

Radiometal-binding peptide analogues

IMMUNOMEDICS INC51 citations96
US6071490AJun 6, 2000

Position emission tomography using gallium-68 chelates

IMMUNOMEDICS INC70 citations96
US5753206AMay 19, 1998

Radiometal-binding analogues of luteinizing hormone releasing hormone

IMMUNOMEDICS INC70 citations96
US8343460B2Jan 1, 2013

Methods and compositions for F-18 labeling of proteins, peptides and molecules

IMMUNOMEDICS INC18 citations93
US7560110B2Jul 14, 2009

Production and use of novel peptide-based agents with bispecific antibodies

IMMUNOMEDICS INC16 citations93
US7429381B2Sep 30, 2008

Production and use of novel peptide-based agents for use with bi-specific antibodies

IMMUNOMEDICS INC14 citations93
US7052872B1May 30, 2006

Bi-specific antibodies for pre-targeting diagnosis and therapy

IMMUNOMEDICS INC49 citations93
US6953675B2Oct 11, 2005

Landscaped antibodies and antibody fragments for clinical use

IMMUNOMEDICS INC43 citations93
US6576746B2Jun 10, 2003

Site-specific labeling of disulfide-containing targeting vectors

IMMUNOMEDICS INC40 citations93
US9694088B2Jul 4, 2017

Pro-drug form (P2PDox) of the highly potent 2-pyrrolinodoxorubicin conjugated to antibodies for targeted therapy of cancer

IMMUNOMEDICS INC11 citations92
US8877202B2Nov 4, 2014

Pro-drug form (P2PDOX) of the highly potent 2-pyrrolinodoxorubicin conjugated to antibodies for targeted therapy of cancer

IMMUNOMEDICS INC27 citations92
US8808665B2Aug 19, 2014

In vivo copper-free click chemistry for delivery of therapeutic and/or diagnostic agents

IMMUNOMEDICS INC17 citations92
US8496912B2Jul 30, 2013

In vivo copper-free click chemistry for delivery of therapeutic and/or diagnostic agents

IMMUNOMEDICS INC16 citations92
US7993626B2Aug 9, 2011

Methods and compositions for F-18 labeling of proteins, peptides and other molecules

IMMUNOMEDICS INC37 citations92
US7534431B2May 19, 2009

Methods and compositions for administering therapeutic and diagnostic agents

IMMUNOMEDICS INC34 citations92
US7405320B2Jul 29, 2008

Therapeutic and diagnostic conjugates for use with multispecific antibodies

IMMUNOMEDICS INC24 citations91
US9352036B2May 31, 2016

Delivery system for cytotoxic drugs by bispecific antibody pretargeting

IMMUNOMEDICS INC12 citations84
US9115172B2Aug 25, 2015

Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules

IMMUNOMEDICS INC7 citations84
US9028800B2May 12, 2015

Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules

IMMUNOMEDICS INC12 citations84

IBC PHARMACEUTICALS INC

8 patents

MCBRIDE WILLIAM J

7 patents

CHANG CHIEN-HSING

6 patents

MEDI PHYSICS INC

2 patents

GOLDENBERG DAVID M

1 patent

D SOUZA CHRISTOPHER A

1 patent

Showing the top 50 of 84 patents by PatentIndex Score.